L
Laura Melinceanu
Publications - 4
Citations - 79
Laura Melinceanu is an academic researcher. The author has contributed to research in topics: Immune system & Tumor microenvironment. The author has an hindex of 4, co-authored 4 publications receiving 75 citations.
Papers
More filters
Journal ArticleDOI
Influence of tumor cell culture supernatants on macrophage functional polarization: in vitro models of macrophage-tumor environment interaction.
Iuliana Caras,Catalin Tucureanu,Lucian Lerescu,Ramona Pitica,Laura Melinceanu,S Neagu,Aurora Salageanu +6 more
TL;DR: Data support the hypothesis that TAM behavior is modulated by the tumor microenvironment itself and suggest that primary tumor cell culture supernatants are able to switch the macrophage phenotype or to induce functional polarization of macrophages toward a mixed M1/M2 phenotype.
Journal Article
Serum perioperative profile of cytokines in patients with squamous cell carcinoma of the larynx.
Laura Melinceanu,Lucian Lerescu,Catalin Tucureanu,Iuliana Caras,Ramona Pitica,Codrut Sarafoleanu,Aurora Salageanu +6 more
TL;DR: Differences noticed in patients' immune mediator profiles seem to be attributable to both disease and treatment, and further longitudinal studies are necessary to elucidate the involvement of immune mediators in disease progression and clinical evolution.
Journal Article
Primary cell culture of human adenocarcinomas--practical considerations.
Lucian Lerescu,Catalin Tucureanu,Iuliana Caras,Stefan Neagu,Laura Melinceanu,Aurora Salageanu +5 more
TL;DR: The present article reviews the critical steps in obtaining, routine maintenance and cryopreservation of primary tumor cell cultures, based on information from literature and personal experience on the subject.
Journal Article
Impact of smoking on the immunological profile of patients with laryngeal carcinoma.
Laura Melinceanu,Codrut Sarafoleanu,Lucian Lerescu,Catalin Tucureanu,Iuliana Caras,Aurora Salageanu +5 more
TL;DR: The results suggested a predominance of a Th2 type of immune response associated with the presence of the tumor (especially in the case of heavy smokers who smoke more than 40 pack–years), however, shifts towards a Th1 type ofimmune response as well as an improvement of monocyte functions were noticed after surgery.